Clinical DataResearch Only
MK-677 Dosing Guide
Evidence-based dosing protocols across 1 administration approach.
Medical Disclaimer
This dosing information is for educational reference only. Dosing decisions require physician oversight. Do not self-prescribe or adjust dosing without consulting a qualified healthcare provider.
Dosing Protocols
GH Secretagogue (Oral)
Clinical TrialOralDose Range
10–25 mg
Frequency
daily
Source
Chapman et al. 1996; PMID 9467534
25 mg/d restored 24-hr mean GH and IGF-1 to young-adult levels in elderly. Phase 2 only. Cardiac safety signal: 6.5% CHF vs 1.7% placebo in hip fracture trial → development stalled.
Administration
Delivery methods
Oral capsuleOral liquid
⏳
Pending physician review — consult your provider before use.Updated 2026-04-10